Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Jan. 31, 2022 | Mar. 03, 2022 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Jan. 31, 2022 | |
Entity File Number | 0-9143 | |
Entity Registrant Name | HURCO COMPANIES, INC. | |
Entity Incorporation, State or Country Code | IN | |
Entity Tax Identification Number | 35-1150732 | |
Entity Address, Address Line One | One Technology Way | |
Entity Address, City or Town | Indianapolis | |
Entity Address, State or Province | IN | |
Entity Address, Postal Zip Code | 46268 | |
City Area Code | 317 | |
Local Phone Number | 293-5309 | |
Title of 12(b) Security | Common Stock, no par value | |
Security Exchange Name | NASDAQ | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Accelerated Filer | |
Entity Small Business | false | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 6,577,044 | |
Entity Central Index Key | 0000315374 | |
Current Fiscal Year End Date | --10-31 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Trading Symbol | HURC |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
CONSOLIDATED STATEMENTS OF OPERATIONS | ||
Sales and service fees | $ 66,887 | $ 54,115 |
Cost of sales and service | 49,980 | 42,568 |
Gross profit | 16,907 | 11,547 |
Selling, general and administrative expenses | 11,697 | 10,568 |
Operating income | 5,210 | 979 |
Interest expense | 7 | 19 |
Interest income | 53 | 16 |
Investment income, net | 178 | 121 |
Other expense (income), net | 256 | (112) |
Income before income taxes | 5,178 | 1,209 |
Provision for income taxes | 1,643 | 546 |
Net income | $ 3,535 | $ 663 |
Income (loss) per common share - basic | $ 0.53 | $ 0.10 |
Income (loss) per common share - diluted | $ 0.53 | $ 0.10 |
Weighted average common shares outstanding - basic | 6,616 | 6,575 |
Weighted average common shares outstanding - diluted | 6,642 | 6,584 |
Dividends paid per share | $ 0.14 | $ 0.13 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) | ||
Net income | $ 3,535 | $ 663 |
Other comprehensive income (loss): | ||
Translation gain (loss) of foreign currency financial statements | (1,510) | 4,184 |
(Gain) / loss on derivative instruments reclassified into operations, net of tax of $46 and $(114), respectively | 149 | (379) |
Gain / (loss) on derivative instruments, net of tax of $104 and $(166), respectively | 335 | (554) |
Total other comprehensive income (loss) | (1,026) | 3,251 |
Comprehensive income | $ 2,509 | $ 3,914 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical) - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) | ||
(Gain) / loss on derivative instruments reclassified into operations, tax | $ 46 | $ (114) |
Gain / (loss) on derivative instruments, tax | $ 104 | $ (166) |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jan. 31, 2022 | Oct. 31, 2021 |
Current assets: | ||
Cash and cash equivalents | $ 90,029 | $ 84,063 |
Accounts receivable, net | 39,183 | 42,620 |
Inventories, net | 152,893 | 148,216 |
Derivative assets | 1,088 | 905 |
Prepaid assets | 9,670 | 13,091 |
Other | 54 | 975 |
Total current assets | 292,917 | 289,870 |
Property and equipment: | ||
Land | 868 | 868 |
Building | 7,352 | 7,352 |
Machinery and equipment | 29,356 | 29,533 |
Leasehold improvements | 5,221 | 5,172 |
Property and equipment, gross | 42,797 | 42,925 |
Less accumulated depreciation and amortization | (32,612) | (32,318) |
Total property and equipment, net | 10,185 | 10,607 |
Non-current assets: | ||
Software development costs, less accumulated amortization | 7,528 | 7,553 |
Intangible assets, net | 1,488 | 1,565 |
Operating lease - right of use assets, net | 9,815 | 10,624 |
Deferred income taxes | 2,923 | 3,154 |
Investments and other assets, net | 9,615 | 9,562 |
Total non-current assets | 31,369 | 32,458 |
Total assets | 334,471 | 332,935 |
Current liabilities: | ||
Accounts payable | 52,599 | 48,881 |
Customer deposits | 8,610 | 8,593 |
Derivative liabilities | 579 | 467 |
Operating lease liabilities | 4,050 | 4,221 |
Accrued payroll and employee benefits | 7,832 | 10,389 |
Accrued income taxes | 2,438 | 1,192 |
Accrued expenses | 4,813 | 5,911 |
Accrued warranty expenses | 1,470 | 1,516 |
Total current liabilities | 82,391 | 81,170 |
Non-current liabilities: | ||
Deferred income taxes | 98 | 68 |
Accrued tax liability | 1,752 | 1,749 |
Operating lease liabilities | 6,150 | 6,794 |
Deferred credits and other | 4,610 | 4,735 |
Total non-current liabilities | 12,610 | 13,346 |
Shareholders' equity: | ||
Preferred stock: no par value per share, 1,000,000 shares authorized; no shares issued | 0 | 0 |
Common stock: no par value, $.10 stated value per share, 12,500,000 shares authorized; 6,681,589 and 6,691,052 shares issued and 6,607,437 and 6,617,717 shares outstanding, as of January 31, 2022 and October 31, 2021, respectively | 661 | 662 |
Additional paid-in capital | 63,404 | 63,924 |
Retained earnings | 178,172 | 175,574 |
Accumulated other comprehensive loss | (2,767) | (1,741) |
Total shareholders' equity | 239,470 | 238,419 |
Total liabilities and shareholders' equity | $ 334,471 | $ 332,935 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Jan. 31, 2022 | Oct. 31, 2021 |
CONSOLIDATED BALANCE SHEETS | ||
Preferred stock, no par value | $ 0 | $ 0 |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 |
Preferred stock, shares issued | 0 | 0 |
Common Stock, No Par Value | $ 0 | $ 0 |
Common stock, stated value per share | $ 0.10 | $ 0.10 |
Common stock, shares authorized | 12,500,000 | 12,500,000 |
Common stock, shares issued | 6,681,589 | 6,691,052 |
Common stock, shares outstanding | 6,607,437 | 6,617,717 |
CONDENSED CONSOLIDATED STATEM_4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
Cash flows from operating activities: | ||
Net income | $ 3,535 | $ 663 |
Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||
Provision for doubtful accounts | (86) | 81 |
Deferred income taxes | (14) | 132 |
Equity in (income) loss of affiliates | (114) | 57 |
Foreign currency (gain) loss | 367 | (956) |
Unrealized (gain) loss on derivatives | 157 | 229 |
Depreciation and amortization | 942 | 1,066 |
Stock-based compensation | 789 | 659 |
Change in assets and liabilities: | ||
(Increase) decrease in accounts receivable | 3,041 | 374 |
(Increase) decrease in inventories | (5,935) | 5,714 |
(Increase) decrease in prepaid expenses | 4,156 | (1,587) |
Increase (decrease) in accounts payable | 3,862 | 1,991 |
Increase (decrease) in customer deposits | 67 | (251) |
Increase (decrease) in accrued expenses | (922) | (22) |
Increase (decrease) in warranty expenses | (35) | 18 |
Increase (decrease) in accrued payroll and employee benefits | (2,557) | 218 |
Increase (decrease) in accrued income tax | 1,257 | 246 |
Net change in derivative assets and liabilities | 48 | (229) |
Other | 853 | 631 |
Net cash provided by (used for) operating activities | 9,411 | 9,034 |
Cash flows from investing activities: | ||
Proceeds from sale of property and equipment | 7 | |
Purchase of property and equipment | (277) | (298) |
Software development costs | (303) | (324) |
Other investments | (262) | (140) |
Net cash provided by (used for) investing activities | (835) | (762) |
Cash flows from financing activities: | ||
Proceeds from exercise of common stock options | 117 | |
Dividends paid | (937) | (865) |
Taxes paid related to net settlement of restricted shares | (208) | (197) |
Stock repurchases | (1,219) | |
Net cash provided by (used for) financing activities | (2,247) | (1,062) |
Effect of exchange rate changes on cash and cash equivalents | (363) | 1,484 |
Net increase (decrease) in cash and cash equivalents | 5,966 | 8,694 |
Cash and cash equivalents at beginning of period | 84,063 | 57,859 |
Cash and cash equivalents at end of period | 90,029 | $ 66,553 |
Cash and cash equivalents at beginning of period | 84,063 | |
Cash and cash equivalents at end of period | $ 90,029 |
CONDENSED CONSOLIDATED STATEM_5
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands | Common Stock | Additional Paid-in Capital | Retained Earnings | Accumulated Other Comprehensive (Loss) | Total |
Balances at Oct. 31, 2020 | $ 657 | $ 60,997 | $ 172,484 | $ (2,990) | $ 231,148 |
Balances (in shares) at Oct. 31, 2020 | 6,565,163 | ||||
Net income | 663 | 663 | |||
Other comprehensive income (loss) | 3,251 | 3,251 | |||
Stock-based compensation expense, net of taxes withheld for vested restricted shares | $ 1 | 461 | 462 | ||
Stock-based compensation expense, net of taxes withheld for vested restricted shares (in shares) | 18,463 | ||||
Dividends paid | (865) | (865) | |||
Balances at Jan. 31, 2021 | $ 658 | 61,458 | 172,282 | 261 | 234,659 |
Balances (in shares) at Jan. 31, 2021 | 6,583,626 | ||||
Balances at Oct. 31, 2021 | $ 662 | 63,924 | 175,574 | (1,741) | 238,419 |
Balances (in shares) at Oct. 31, 2021 | 6,617,717 | ||||
Net income | 3,535 | 3,535 | |||
Other comprehensive income (loss) | (1,026) | (1,026) | |||
Stock-based compensation expense, net of taxes withheld for vested restricted shares | $ 2 | 579 | 581 | ||
Stock-based compensation expense, net of taxes withheld for vested restricted shares (in shares) | 24,440 | ||||
Exercise of common stock options | $ 1 | 116 | 117 | ||
Exercise of common stock options (in shares) | 5,437 | ||||
Stock repurchases | $ (4) | (1,215) | (1,219) | ||
Stock repurchases (in shares) | (40,157) | ||||
Dividends paid | (937) | (937) | |||
Balances at Jan. 31, 2022 | $ 661 | $ 63,404 | $ 178,172 | $ (2,767) | $ 239,470 |
Balances (in shares) at Jan. 31, 2022 | 6,607,437 |
GENERAL
GENERAL | 3 Months Ended |
Jan. 31, 2022 | |
GENERAL | |
GENERAL | 1. GENERAL The unaudited Condensed Consolidated Financial Statements include the accounts of Hurco Companies, Inc. and its consolidated subsidiaries. As used in this report, the words “we”, “us”, “our”, “Hurco” and the “Company” refer to Hurco Companies, Inc. and its consolidated subsidiaries. We design, manufacture, and sell computerized (i.e., Computer Numeric Control (“CNC”)) machine tools, consisting primarily of vertical machining centers (mills) and turning centers (lathes), to companies in the metal cutting industry through a worldwide sales, service, and distribution network. Although the majority of our computer control systems and software products are proprietary, they predominantly use industry standard personal computer components. Our computer control systems and software products are primarily sold as integral components of our computerized machine tool products. We also provide machine tool components, automation integration equipment and solutions for job shops, software options, control upgrades, accessories and replacement parts for our products, as well as customer service, training, and applications support. We operate in the industrial equipment industry and have a global footprint that subjects us to various business risks in many different countries. Our operating results during fiscal years 2020, 2021 and the first quarter of fiscal 2022 were affected by the international business disruption due to the outbreak of COVID-19, vendor delays, transportation issues, inflationary cost pressures, competitive labor markets, uncertainty surrounding the U.K. Brexit activities, and political friction in the U.S and many regions of the world. Because of the potential for extended vulnerability, we have closely evaluated the estimates we have made in preparing the financial statements as of January 31, 2022, with the understanding that these estimates could change in the near term. We will continue to evaluate and disclose any uncertainty associated with key assumptions underlying fair value estimates, trends, and uncertainties that have had, or are reasonably expected to have, a material effect on our consolidated financial position, results of operations, changes in shareholders' equity, and cash flows for and at the end of each interim period. The condensed financial information as of January 31, 2022 and for the three months ended January 31, 2022 and January 31, 2021 is unaudited. However, in our opinion, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary to present fairly our consolidated financial position, results of operations, changes in shareholders’ equity and cash flows for and at the end of the interim periods. We suggest that you read these Condensed Consolidated Financial Statements in conjunction with the financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended October 31, 2021. |
REVENUE RECOGNITION
REVENUE RECOGNITION | 3 Months Ended |
Jan. 31, 2022 | |
REVENUE RECOGNITION | |
REVENUE RECOGNITION | 2. REVENUE RECOGNITION We design, manufacture and sell computerized machine tools. Our computer control systems and software products are primarily sold as integral components of our computerized machine tool products. We also provide machine tool components, automation integration equipment and solutions for job shops, software options, control upgrades, accessories and replacement parts for our products, as well as customer service, training and applications support. We recognize revenues from the sale of machine tools, components and accessories, and services and reflect the consideration to which we expect to be entitled. We record revenues based on a five-step model in accordance with Financial Accounting Standards Board (“FASB”) guidance codified in Accounting Standard Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). In accordance with ASC 606, we have defined contracts as agreements with our customers and distributors in the form of purchase orders, packing or shipping documents, invoices, and, periodically, verbal requests for components and accessories. For each contract, we identify our performance obligations, which are delivering goods or services, determine the transaction price, allocate the contract transaction price to each of the performance obligations (when applicable), and recognize the revenue when (or as) the performance obligation to the customer is fulfilled. A good or service is transferred when the customer obtains control of that good or service. Our computerized machine tools are general purpose computer-controlled machine tools that are typically used in stand-alone operations. Prior to shipment, we test each machine to ensure the machine’s compliance with standard operating specifications. We deem that the customer obtains control upon delivery of the product and that obtaining control is not contingent upon contractual customer acceptance. Therefore, we recognize revenue from sales of our machine tool systems upon delivery of the product to the customer or distributor, which is normally at the time of shipment. Depending upon geographic location, after shipment, a machine may be installed at the customer’s facility by a distributor, independent contractor, or by one of our service technicians. In most instances, where a machine is sold through a distributor, we have no installation involvement. If sales are direct or through sales agents, we will typically complete the machine installation, which consists of the reassembly of certain parts that were removed for shipping and the re-testing of the machine to ensure that it is performing within the standard specifications. We consider the machine installation process for our three-axis machines to be inconsequential and immaterial within the context of the contract. For our five-axis machines that we install, we estimate the fair value of the installation performance obligation and recognize that installation revenue on a prorata basis over the period of the installation process. From time to time, and depending upon geographic location, we may provide training or freight services. We consider these services to be immaterial within the context of the contract, as the value of these services typically does not rise to a material level as a component of the total contract value. Service fees from maintenance contracts are deferred and recognized in earnings on a prorata basis over the term of the contract and are generally sold on a stand-alone basis. Customer discounts and estimated product returns are considered variable consideration and are recorded as a reduction of revenue in the same period that the related sales are recorded. We have reviewed the overall sales transactions for variable consideration and have determined that these amounts are not significant. |
DERIVATIVE INSTRUMENTS AND HEDG
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES | 3 Months Ended |
Jan. 31, 2022 | |
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES | |
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES | 3. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES We are exposed to certain market risks relating to our ongoing business operations, including foreign currency risk, interest rate risk and credit risk. We manage our exposure to these and other market risks through regular operating and financing activities. Currently, the only risk that we manage through the use of derivative instruments is foreign currency risk, for which we enter into derivative instruments in the form of foreign currency forward exchange contracts with a few major financial institutions. We enter into these forward exchange contracts to reduce the potential effects of foreign exchange rate movements on our net equity investment in one of our foreign subsidiaries, to reduce the impact on gross profit and net earnings from sales and purchases denominated in foreign currencies, and to reduce the impact on our net earnings of foreign currency fluctuations on receivables and payables denominated in foreign currencies that are different than the subsidiaries’ functional currency. We are primarily exposed to foreign currency exchange rate risk with respect to transactions and net assets denominated in Euros, Pounds Sterling, Indian Rupee, Singapore Dollars, Chinese Yuan, Polish Zloty, and New Taiwan Dollars. We record all derivative instruments as assets or liabilities at fair value. Derivatives Designated as Hedging Instruments We enter into foreign currency forward exchange contracts periodically to hedge certain forecasted inter-company sales and purchases denominated in the following foreign currencies: the Pound Sterling, Euro and New Taiwan Dollar. The purpose of these instruments is to mitigate the risk that the U.S. Dollar net cash inflows and outflows resulting from sales and purchases denominated in foreign currencies will be adversely affected by changes in exchange rates. These forward contracts have been designated as cash flow hedge instruments and are recorded in the Condensed Consolidated Balance Sheets at fair value in Derivative assets and Derivative liabilities. The effective portion of the gains and losses resulting from the changes in the fair value of these hedge contracts is deferred in Accumulated other comprehensive income (loss) and recognized as an adjustment to Cost of sales and service in the period that the corresponding inventory sold that is the subject of the related hedge contract is recognized, thereby providing an offsetting economic impact against the corresponding change in the U.S. Dollar value of the inter-company sale or purchase being hedged. The ineffective portion of gains and losses resulting from the changes in the fair value of these hedge contracts is immediately reported in Other expense (income), net. We perform quarterly assessments of hedge effectiveness by verifying and documenting the critical terms of the hedge instrument and determining that forecasted transactions have not changed significantly. We also assess on a quarterly basis whether there have been adverse developments regarding the risk of a counterparty default. We had forward contracts outstanding as of January 31, 2022, denominated in Euros, Pounds Sterling and New Taiwan Dollars with set maturity dates ranging from February 2022 through January 2023. The contract amounts, expressed at forward rates in U.S. Dollars at January 31, 2022, were $23.6 million for Euros, $8.8 million for Pounds Sterling and $31.4 million for New Taiwan Dollars. At January 31, 2022, we had approximately $335,000 of gains, net of tax, related to cash flow hedges deferred in Accumulated other comprehensive income (loss). Included in this amount was $313,000 of unrealized gains, net of tax, related to cash flow hedge instruments that remain subject to currency fluctuation risk. The majority of these deferred gains will be recorded as an adjustment to Cost of sales and service in periods through January 2023, when the corresponding inventory that is the subject of the related hedge contracts is sold, as described above. We are also exposed to foreign currency exchange risk related to our investment in net assets in foreign countries. To manage this risk, we entered into a forward contract with a notional amount of €3.0 million in November 2021. We designated this forward contract as a hedge of our net investment in Euro denominated assets. We selected the forward method under FASB guidance related to the accounting for derivative instruments and hedging activities. The forward method requires all changes in the fair value of the contract to be reported as a cumulative translation adjustment in Accumulated other comprehensive income (loss), net of tax, in the same manner as the underlying hedged net assets. This forward contract matures in November 2022. As of January 31, 2022, we had a realized gain of $0.9 million and an unrealized gain of $68,000, net of tax, recorded as cumulative translation adjustments in Accumulated other comprehensive income (loss) related to this forward contract. Derivatives Not Designated as Hedging Instruments We also enter into foreign currency forward exchange contracts to protect against the effects of foreign currency fluctuations on inter-company receivables, payables and loans denominated in foreign currencies. These derivative instruments are not designated as hedges under FASB guidance and, as a result, changes in their fair value are reported currently in Other expense (income), net in the Condensed Consolidated Statements of Operations consistent with the transaction gain or loss on the related receivables and payables denominated in foreign currencies. We had forward contracts outstanding as of January 31, 2022, denominated in Euros, Pounds Sterling, and New Taiwan Dollars with set maturity dates ranging from February 2022 through July 2022. The contract amounts, expressed at forward rates in U.S. Dollars at January 31, 2022, totaled $38.8 million. Fair Value of Derivative Instruments We recognize the fair value of derivative instruments as assets and liabilities on a gross basis on our Condensed Consolidated Balance Sheets. As of January 31, 2022 and October 31, 2021, all derivative instruments were recorded at fair value on our Condensed Consolidated Balance Sheets as follows (in thousands): January 31, 2022 October 31, 2021 Balance Sheet Fair Balance Sheet Fair Derivatives Location Value Location Value Designated as Hedging Instruments: Foreign exchange forward contracts Derivative assets $ 917 Derivative assets $ 646 Foreign exchange forward contracts Derivative liabilities $ 440 Derivative liabilities $ 403 Not Designated as Hedging Instruments: Foreign exchange forward contracts Derivative assets $ 171 Derivative assets $ 259 Foreign exchange forward contracts Derivative liabilities $ 139 Derivative liabilities $ 64 Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Changes in Shareholders’ Equity and Condensed Consolidated Statements of Operations Derivative instruments had the following effects on our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Changes in Shareholders’ Equity and Condensed Consolidated Statements of Operations, net of tax, during the three months ended January 31, 2022 and 2021 (in thousands): Location of Gain Amount of Gain Amount of Gain (Loss) (Loss) Reclassified (Loss) Reclassified Recognized in Other from Other from Other Comprehensive Comprehensive Comprehensive Derivatives Income (Loss) Income (Loss) Income (Loss) Three Months Ended Three Months Ended January 31, January 31, 2022 2021 2022 2021 Designated as Hedging Instruments: (Effective portion) Foreign exchange forward contracts $ 335 $ (554) Cost of sales and service $ (149) $ 379 Foreign exchange forward contract $ 69 $ (110) We did not recognize any gains or losses as a result of hedges deemed ineffective for either of the three months ended January 31, 2022 or 2021. We recognized the following gains and losses in our Condensed Consolidated Statements of Operations during the three months ended January 31, 2022 and 2021 on derivative instruments not designated as hedging instruments (in thousands): Location of Gain (Loss) Recognized Amount of Gain (Loss) Derivatives in Operations Recognized in Operations Three Months Ended January 31, 2022 2021 Not Designated as Hedging Instruments: Foreign exchange forward contracts Other expense (income), net $ 198 $ (813) The following table presents the changes in the components of Accumulated other comprehensive income (loss), net of tax, for the three months ended January 31, 2022 (in thousands): Foreign Currency Cash Flow Translation Hedges Total Balance, October 31, 2021 $ (1,668) $ (73) $ (1,741) Other comprehensive income (loss) before reclassifications (1,510) 335 (1,175) Reclassifications — 149 149 Balance, January 31, 2022 $ (3,178) $ 411 $ (2,767) |
EQUITY INCENTIVE PLAN
EQUITY INCENTIVE PLAN | 3 Months Ended |
Jan. 31, 2022 | |
EQUITY INCENTIVE PLAN | |
EQUITY INCENTIVE PLAN | 4. EQUITY INCENTIVE PLAN In March 2016, we adopted the Hurco Companies, Inc. 2016 Equity Incentive Plan (the “2016 Equity Plan”), which allows us to grant awards of stock options, stock appreciation rights, restricted stock, stock units and other stock-based awards. The 2016 Equity Plan replaced the Hurco Companies, Inc. 2008 Equity Incentive Plan (the “2008 Equity Plan”) and is the only active plan under which equity awards may be made by us to our employees and non-employee directors. No further awards will be made under our 2008 Equity Plan. The total number of shares of our common stock that may be issued pursuant to awards under the 2016 Equity Plan is 856,048, which includes 386,048 shares remaining available for future grants under the 2008 Equity Plan as of March 10, 2016, the date our shareholders approved the 2016 Equity Plan. The Compensation Committee of our Board of Directors has the authority to determine the officers, directors and key employees who will be granted awards under the 2016 Equity Plan; designate the number of shares subject to each award; determine the terms and conditions upon which awards will be granted; and prescribe the form and terms of award agreements. We have granted restricted shares and performance units under the 2016 Equity Plan that are currently outstanding, and we have granted stock options under the 2008 Equity Plan that are currently outstanding. No stock option may be exercised more than ten years after the date of grant or such shorter period as the Compensation Committee may determine at the date of grant. The market value of a share of our common stock, for purposes of the 2016 Equity Plan, is the closing sale price as reported by the Nasdaq Global Select Market on the date in question or, if not a trading day, on the last preceding trading date. A summary of stock option activity for the three-month period ended January 31, 2022, is as follows: Weighted Average Stock Options Exercise Price Outstanding at October 31, 2021 16,996 $ 22.71 Options granted — — Options exercised (5,437) 21.45 Options cancelled — — Outstanding at January 31, 2022 11,559 $ 23.30 Summarized information about outstanding stock options as of January 31, 2022, that have already vested and are currently exercisable, are as follows: Options Already Vested and Currently Exercisable Number of outstanding options 11,559 Weighted average remaining contractual life (years) 0.86 Weighted average exercise price per share $ 23.30 Intrinsic value of outstanding options $ 103,000 The intrinsic value of an outstanding stock option is calculated as the difference between the stock price as of January 31, 2022 and the exercise price of the option. On January 4, 2022, the Compensation Committee approved a long-term incentive compensation arrangement for our executive officers in the form of time-based restricted shares and performance stock units (“PSUs”) under the 2016 Equity Plan, which will be payable in shares of our common stock if earned and vested. The awards were approximately 25% time-based vesting and approximately 75% performance-based vesting. The three-year performance period for the PSUs is fiscal 2022 through fiscal 2024. On that date, the Compensation Committee granted a total of 23,442 shares of time-based restricted stock to our executive officers. The restricted shares vest in thirds over three years from the date of grant provided the recipient remains employed through that date. The grant date fair value of the restricted shares was based upon the closing sales price of our common stock on the date of grant, which was $30.39 per share. On January 4, 2022, the Compensation Committee also granted a total target number of 34,203 PSUs to our executive officers designated as “PSU – TSR”. These PSUs were weighted as approximately 40% of the overall 2022 executive long-term incentive compensation arrangement and will vest and be paid based upon the total shareholder return of our common stock over the three-year period of fiscal 2022-2024, relative to the total shareholder return of the companies in a specified peer group over that period. Participants will have the ability to earn between 50% of the target number of the PSUs – TSR for achieving threshold performance and 200% of the target number of the PSUs – TSR for achieving maximum performance. The grant date fair value of the PSUs – TSR was $33.33 per PSU and was calculated using the Monte Carlo approach. On January 4, 2022, the Compensation Committee also granted a total target number of 32,821 PSUs to our executive officers designated as “PSU – ROIC”. These PSUs were weighted as approximately 35% of the overall 2022 executive long-term incentive compensation arrangement and will vest and be paid based upon the achievement of pre-established goals related to our average return on invested capital over the three-year period of fiscal 2022-2024. Participants will have the ability to earn between 50% of the target number of the PSUs – ROIC for achieving threshold performance and 200% of the target number of the PSUs – ROIC for achieving maximum performance. The grant date fair value of the PSUs – ROIC was based on the closing sales price of our common stock on the grant date, which was $30.39 per share. On November 10, 2021, the Compensation Committee granted a total of 8,234 shares of time-based restricted stock to our non-executive employees. The restricted shares vest in thirds over three years from the date of grant provided the recipient remains employed through that date. The grant date fair value of the restricted shares was based upon the closing sales price of our common stock on the date of grant, which was $33.99 per share. A reconciliation of our restricted stock and PSU activity and related information for the three-month period ended January 31, 2022 is as follows: Weighted Average Grant Number of Shares Date Fair Value Unvested at October 31, 2021 262,556 $ 34.84 Shares or units granted 98,700 31.71 Shares or units vested (24,053) 34.03 Shares or units cancelled (61,500) 38.41 Shares withheld (6,806) 34.03 Unvested at January 31, 2022 268,897 $ 32.97 During the first three months of fiscal 2022 and 2021, we recorded approximately $0.8 million and $0.7 million, respectively, of stock-based compensation expense related to grants under the 2016 Equity Plan. As of January 31, 2022, there was an estimated $5.9 million of total unrecognized stock-based compensation cost that we expect to recognize by the end of the first quarter of fiscal 2025. |
EARNINGS PER SHARE
EARNINGS PER SHARE | 3 Months Ended |
Jan. 31, 2022 | |
EARNINGS PER SHARE | |
EARNINGS PER SHARE | 5. EARNINGS PER SHARE Per share results have been computed based on the average number of common shares outstanding over the period in question. The computation of basic and diluted net income per share is determined using net income applicable to common shareholders as the numerator and the number of shares outstanding as the denominator as follows (in thousands, except per share amounts): January 31, 2022 2021 (in thousands, except per share amounts) Basic Diluted Basic Diluted Net income $ 3,535 $ 3,535 $ 663 $ 663 Undistributed earnings allocated to participating shares (39) (39) (8) (8) Net income applicable to common shareholders $ 3,496 $ 3,496 $ 655 $ 655 Weighted average shares outstanding 6,616 6,616 6,575 6,575 Stock options and contingently issuable securities — 26 — 9 6,616 6,642 6,575 6,584 Income per share $ 0.53 $ 0.53 $ 0.10 $ 0.10 |
ACCOUNTS RECEIVABLE
ACCOUNTS RECEIVABLE | 3 Months Ended |
Jan. 31, 2022 | |
ACCOUNTS RECEIVABLE | |
ACCOUNTS RECEIVABLE | 6. ACCOUNTS RECEIVABLE Accounts receivable are net of allowances for doubtful accounts of $1.6 million as of January 31, 2022 and $1.6 million as of October 31, 2021. |
INVENTORIES
INVENTORIES | 3 Months Ended |
Jan. 31, 2022 | |
INVENTORIES | |
INVENTORIES | 7. INVENTORIES Inventories, priced at the lower of cost (first-in, first-out method) or net realizable value, are summarized below (in thousands): January 31, October 31, 2022 2021 Purchased parts and sub–assemblies $ 44,011 $ 37,527 Work–in–process 17,483 17,559 Finished goods 91,399 93,130 $ 152,893 $ 148,216 |
LEASES
LEASES | 3 Months Ended |
Jan. 31, 2022 | |
LEASES | |
LEASES | 8. LEASES We adopted Accounting Standards Update (“ASU”) No. 2016-02, “Leases” (“ASC 842”) on November 1, 2019. Our lease portfolio includes leased production and assembly facilities, warehouses and distribution centers, office space, vehicles, material handling equipment utilized in our production and assembly facilities, laptops and other information technology equipment, as well as other miscellaneous leased equipment. Most of the leased production and assembly facilities have lease terms ranging from two In accordance with ASC 842, we record a right-of-use asset and lease liability on our Condensed Consolidated Balance Sheets for all leases that, at the commencement date, have a lease term of more than 12 months and are classified as operating leases. We recorded total operating lease expense of $1.3 million for each of the three months ended January 31, 2022 and 2021, which is classified within Cost of sales and service and Selling, general and administrative expenses within the Condensed Consolidated Statements of Operations. Operating lease expense includes short-term leases and variable lease payments which are immaterial. There have been no lease costs capitalized on the Condensed Consolidated Balance Sheets as of January 31, 2022. The following table summarizes supplemental cash flow information and non-cash activity related to operating leases for the three months ended January 31, 2022 (in thousands): Three Months Ended January 31, 2022 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 1,219 Non-cash information: Right-of-use assets obtained in exchange for new operating lease liabilities $ 849 The following table summarizes the maturities of undiscounted cash flows of lease commitments reconciled to the total lease liability as of January 31, 2022 (in thousands): Remainder of 2022 $ 3,347 2023 3,122 2024 1,525 2025 841 2026 609 2026 and thereafter 1,089 Total 10,533 Less: Imputed interest (333) Present value of operating lease liabilities $ 10,200 As of January 31, 2022, the weighted-average remaining term of our lease portfolio was approximately 3.7 years and the weighted-average discount rate was approximately 1.7%. |
SEGMENT INFORMATION
SEGMENT INFORMATION | 3 Months Ended |
Jan. 31, 2022 | |
SEGMENT INFORMATION | |
SEGMENT INFORMATION | 9. SEGMENT INFORMATION We operate in a single segment |
GUARANTEES AND PRODUCT WARRANTI
GUARANTEES AND PRODUCT WARRANTIES | 3 Months Ended |
Jan. 31, 2022 | |
GUARANTEES AND PRODUCT WARRANTIES | |
GUARANTEES AND PRODUCT WARRANTIES | 10. GUARANTEES AND PRODUCT WARRANTIES From time to time, our subsidiaries guarantee third party payment obligations in connection with the sale of machines to customers that use financing. We follow FASB guidance for accounting for guarantees (codified in ASC 460). As of January 31, 2022, we had eight outstanding third party payment guarantees totaling approximately $0.8 million. The terms of these guarantees are consistent with the underlying customer financing terms. Upon shipment of a machine, the customer assumes the risk of ownership. The customer does not obtain title, however, until it has paid for the machine. A retention of title clause allows us to recover the machine if the customer defaults on the financing. We accrue liabilities under these guarantees at fair value, which amounts are insignificant. We provide warranties on our products with respect to defects in material and workmanship. The terms of these warranties are generally one year for machines and shorter periods for service parts. We recognize a reserve with respect to this obligation at the time of product sale, with subsequent warranty claims recorded against the reserve. The amount of the warranty reserve is determined based on historical trend experience and any known warranty issues that could cause future warranty costs to differ from historical experience. A reconciliation of the changes in our warranty reserve is as follows (in thousands): Three Months Ended January 31, 2022 2021 Balance, beginning of period $ 1,516 $ 1,200 Provision for warranties during the year 646 713 Charges to the reserve (680) (722) Impact of foreign currency translation (12) 55 Balance, end of period $ 1,470 $ 1,246 The year-over-year increase in our warranty reserve was primarily due to an increase in the number of machines under warranty from increased sales volume. |
DEBT AGREEMENTS
DEBT AGREEMENTS | 3 Months Ended |
Jan. 31, 2022 | |
DEBT AGREEMENTS | |
DEBT AGREEMENTS | 11. DEBT AGREEMENTS On December 31, 2018, we and our subsidiary Hurco B.V. entered into a credit agreement with Bank of America, N.A., as the lender, which was subsequently amended on each of March 13, 2020, December 23, 2020 and December 17, 2021 (as amended, the “2018 Credit Agreement”). The 2018 Credit Agreement provides for an unsecured revolving credit and letter of credit facility in a maximum aggregate amount of $40.0 million. The 2018 Credit Agreement provides that the maximum amount of outstanding letters of credit at any one time may not exceed $10.0 million, the maximum amount of outstanding loans made to our subsidiary Hurco B.V. at any one time may not exceed $20.0 million, and the maximum amount of all outstanding loans denominated in alternative currencies at any one time may not exceed $20.0 million. Under the 2018 Credit Agreement, we and Hurco B.V. are borrowers, and certain of our other subsidiaries are guarantors. The scheduled maturity date of the 2018 Credit Agreement is December 31, 2023. Borrowings under the 2018 Credit Agreement bear interest at floating rates based on, at our option, either (i) a rate based upon the secured overnight financing rate (“SOFR”), the Sterling Overnight Index Average Reference Rate, the Euro Interbank Offering Rate, or another alternative currency-based rate approved by the lender, depending on the term of the loan and the currency in which such loan is denominated, plus 1.00% per annum, or (ii) a base rate (which is the highest of (a) the federal funds rate plus 0.50%, (b) the prime rate or (c) the one month SOFR-based rate plus 1.00%), plus 0.00% per annum. Outstanding letters of credit will carry an annual rate of 1.00%. The 2018 Credit Agreement contains customary affirmative and negative covenants and events of default, including covenants (1) restricting us from making certain investments, loans, advances and acquisitions (but permitting us to make investments in subsidiaries of up to $10.0 million); (2) restricting us from making certain payments, including (a) cash dividends, except that we may pay cash dividends as long as immediately before and after giving effect to such payment, the sum of the unused amount of the commitments under the 2018 Credit Agreement plus our cash on hand is not less than $10.0 million, and as long as we are not in default before and after giving effect to such dividend payments and (b) payments made to repurchase shares of our common stock, except that we may repurchase shares of our common stock as long as we are not in default before and after giving effect to such repurchases and the aggregate amount of payments made by us for all such repurchases during any fiscal year does not exceed $10.0 million; (3) requiring that we maintain a minimum working capital of $125.0 million; and (4) requiring that we maintain a minimum tangible net worth of $176.5 million. We may use the proceeds from advances under the 2018 Credit Agreement for general corporate purposes. In March 2019, our wholly-owned subsidiaries in Taiwan (Hurco Manufacturing Limited (“HML”)), and China, (Ningbo Hurco Machine Tool, Ltd. (“NHML”)), closed on uncommitted revolving credit facilities with maximum aggregate amounts of 150 million New Taiwan Dollars and 32.5 million Chinese Yuan, respectively. As uncommitted facilities, both the Taiwan and China credit facilities are subject to review and termination by the respective underlying lending institution from time to time. As a result, as of January 31, 2022, our existing credit facilities consisted of the €1.5 million revolving credit facility in Germany, the 150 million New Taiwan Dollars Taiwan credit facility, the 32.5 million Chinese Yuan China credit facility and the $40.0 million revolving credit facility under the 2018 Credit Agreement. As of January 31, 2022, there were no borrowings under any of our credit facilities and there was approximately $52.2 million of available borrowing capacity thereunder. |
INCOME TAXES
INCOME TAXES | 3 Months Ended |
Jan. 31, 2022 | |
INCOME TAXES | |
INCOME TAXES | 12. INCOME TAXES Our provision for income taxes and effective tax rate are affected by the geographical composition of pre-tax income that includes jurisdictions with differing tax rates, conditional reduced tax rates, and other events that are not consistent from period to period, such as changes in income tax laws. We recorded an income tax expense for the first three months of fiscal 2022 of $1.6 million compared to $0.5 million for the same period in 2021. Our effective tax rate for the first three months of fiscal 2022 was 32%, compared to 45% in the corresponding prior year period. The decrease in the effective tax rate was primarily due to changes in geographic mix of income and loss that includes jurisdictions with differing tax rates, various discrete tax items, and changes in income tax laws to address the unfavorable impact of the COVID-19 pandemic. Our unrecognized tax benefits were $202,000 as of January 31, 2022, and $198,000 as of October 31, 2021, and in each case included accrued interest. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. As of January 31, 2022, the gross amount of interest accrued, reported in Accrued expenses, was approximately $32,000, which did not include the federal tax benefit of interest deductions. We file U.S. federal and state income tax returns, as well as tax returns in several foreign jurisdictions. The statutes of limitations with respect to unrecognized tax benefits will expire between August 2022 and August 2025. Currently, our subsidiary in Taiwan is under tax audit for fiscal year 2018. |
FINANCIAL INSTRUMENTS
FINANCIAL INSTRUMENTS | 3 Months Ended |
Jan. 31, 2022 | |
FINANCIAL INSTRUMENTS | |
FINANCIAL INSTRUMENTS | 13. FINANCIAL INSTRUMENTS FASB fair value guidance establishes a three-tier fair value hierarchy, which categorizes the inputs used in measuring fair value. These tiers include: Level 1, defined as observable inputs, such as quoted prices in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3, defined as unobservable inputs in which little or no market data exist, therefore requiring an entity to develop its own assumptions. In accordance with this guidance, the following table represents the fair value hierarchy for our financial assets and liabilities measured at fair value as of January 31, 2022 and October 31, 2021 (in thousands): Assets Liabilities January 31, 2022 October 31, 2021 January 31, 2022 October 31, 2021 Level 1 Deferred compensation $ 2,355 $ 2,481 $ — $ — Level 2 Derivatives $ 1,088 $ 905 $ 579 $ 467 Included in Level 1 assets are mutual fund investments under a nonqualified deferred compensation plan. We estimate the fair value of these investments on a recurring basis using market prices that are readily available. Included in Level 2 fair value measurements are derivative assets and liabilities related to gains and losses on foreign currency forward exchange contracts entered into with a third party. We estimate the fair value of these derivatives on a recurring basis using foreign currency exchange rates obtained from active markets. Derivative instruments are reported in the accompanying Condensed Consolidated Financial Statements at fair value. We have derivative financial instruments in the form of foreign currency forward exchange contracts as described in Note 3 of Notes to the Condensed Consolidated Financial Statements. The U.S. Dollar equivalent notional amounts of these contracts was $107.5 million and $94.6 million at January 31, 2022 and October 31, 2021, respectively. The fair value of our foreign currency forward exchange contracts and the related currency positions are subject to offsetting market risk resulting from foreign currency exchange rate volatility. The counterparties to the forward exchange contracts are substantial and creditworthy financial institutions. We do not consider either the risk of counterparties’ non-performance or the economic consequences of counterparties’ non-performance to be material risks. |
CONTINGENCIES AND LITIGATION
CONTINGENCIES AND LITIGATION | 3 Months Ended |
Jan. 31, 2022 | |
CONTINGENCIES AND LITIGATION | |
CONTINGENCIES AND LITIGATION | 14. CONTINGENCIES AND LITIGATION From time to time, we are involved in various claims and lawsuits arising in the normal course of business. Pursuant to applicable accounting rules, we accrue the minimum liability for each known claim when the estimated outcome is a range of possible loss and no one amount within that range is more likely than another. We maintain insurance policies for such matters, and we record insurance recoveries when we determine such recovery to be probable. We do not expect any of these claims, individually or in the aggregate, to have a material adverse effect on our consolidated financial position or results of operations. We believe that the ultimate resolution of claims for any losses will not exceed our insurance policy coverages. |
NEW ACCOUNTING PRONOUNCEMENTS
NEW ACCOUNTING PRONOUNCEMENTS | 3 Months Ended |
Jan. 31, 2022 | |
NEW ACCOUNTING PRONOUNCEMENTS | |
NEW ACCOUNTING PRONOUNCEMENTS | 15. NEW ACCOUNTING PRONOUNCEMENTS Recently Adopted Accounting Pronouncements: In December 2019, FASB issued ASU No. 2019-12, Income Taxes In March 2020, FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting. There have been no other significant changes in the Company’s critical accounting policies and estimates during the three months ended January 31, 2022. |
DERIVATIVE INSTRUMENTS AND HE_2
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
Schedule of Fair Value of Derivative Instruments | January 31, 2022 October 31, 2021 Balance Sheet Fair Balance Sheet Fair Derivatives Location Value Location Value Designated as Hedging Instruments: Foreign exchange forward contracts Derivative assets $ 917 Derivative assets $ 646 Foreign exchange forward contracts Derivative liabilities $ 440 Derivative liabilities $ 403 Not Designated as Hedging Instruments: Foreign exchange forward contracts Derivative assets $ 171 Derivative assets $ 259 Foreign exchange forward contracts Derivative liabilities $ 139 Derivative liabilities $ 64 |
Schedule of derivative instruments not designated as hedging instruments | Location of Gain (Loss) Recognized Amount of Gain (Loss) Derivatives in Operations Recognized in Operations Three Months Ended January 31, 2022 2021 Not Designated as Hedging Instruments: Foreign exchange forward contracts Other expense (income), net $ 198 $ (813) |
Schedule of changes in the components of Accumulated other comprehensive loss, net of tax | The following table presents the changes in the components of Accumulated other comprehensive income (loss), net of tax, for the three months ended January 31, 2022 (in thousands): Foreign Currency Cash Flow Translation Hedges Total Balance, October 31, 2021 $ (1,668) $ (73) $ (1,741) Other comprehensive income (loss) before reclassifications (1,510) 335 (1,175) Reclassifications — 149 149 Balance, January 31, 2022 $ (3,178) $ 411 $ (2,767) |
Designated as Hedging Instrument | |
Schedule of Effect of Derivative Instruments on the Balance Sheets, Statements of Changes in Shareholders' Equity and Statements of Operations | Location of Gain Amount of Gain Amount of Gain (Loss) (Loss) Reclassified (Loss) Reclassified Recognized in Other from Other from Other Comprehensive Comprehensive Comprehensive Derivatives Income (Loss) Income (Loss) Income (Loss) Three Months Ended Three Months Ended January 31, January 31, 2022 2021 2022 2021 Designated as Hedging Instruments: (Effective portion) Foreign exchange forward contracts $ 335 $ (554) Cost of sales and service $ (149) $ 379 Foreign exchange forward contract $ 69 $ (110) |
EQUITY INCENTIVE PLAN (Tables)
EQUITY INCENTIVE PLAN (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
EQUITY INCENTIVE PLAN | |
Schedule of stock option activity | A summary of stock option activity for the three-month period ended January 31, 2022, is as follows: Weighted Average Stock Options Exercise Price Outstanding at October 31, 2021 16,996 $ 22.71 Options granted — — Options exercised (5,437) 21.45 Options cancelled — — Outstanding at January 31, 2022 11,559 $ 23.30 |
Schedule of outstanding stock options | Summarized information about outstanding stock options as of January 31, 2022, that have already vested and are currently exercisable, are as follows: Options Already Vested and Currently Exercisable Number of outstanding options 11,559 Weighted average remaining contractual life (years) 0.86 Weighted average exercise price per share $ 23.30 Intrinsic value of outstanding options $ 103,000 |
Schedule of reconciliation of our restricted stock, performance share and PSU activity and related information | A reconciliation of our restricted stock and PSU activity and related information for the three-month period ended January 31, 2022 is as follows: Weighted Average Grant Number of Shares Date Fair Value Unvested at October 31, 2021 262,556 $ 34.84 Shares or units granted 98,700 31.71 Shares or units vested (24,053) 34.03 Shares or units cancelled (61,500) 38.41 Shares withheld (6,806) 34.03 Unvested at January 31, 2022 268,897 $ 32.97 |
EARNINGS PER SHARE (Tables)
EARNINGS PER SHARE (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
EARNINGS PER SHARE | |
Schedule of computation of basic and diluted net income (loss) per share | January 31, 2022 2021 (in thousands, except per share amounts) Basic Diluted Basic Diluted Net income $ 3,535 $ 3,535 $ 663 $ 663 Undistributed earnings allocated to participating shares (39) (39) (8) (8) Net income applicable to common shareholders $ 3,496 $ 3,496 $ 655 $ 655 Weighted average shares outstanding 6,616 6,616 6,575 6,575 Stock options and contingently issuable securities — 26 — 9 6,616 6,642 6,575 6,584 Income per share $ 0.53 $ 0.53 $ 0.10 $ 0.10 |
INVENTORIES (Tables)
INVENTORIES (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
INVENTORIES | |
Schedule of inventories | Inventories, priced at the lower of cost (first-in, first-out method) or net realizable value, are summarized below (in thousands): January 31, October 31, 2022 2021 Purchased parts and sub–assemblies $ 44,011 $ 37,527 Work–in–process 17,483 17,559 Finished goods 91,399 93,130 $ 152,893 $ 148,216 |
LEASES (Tables)
LEASES (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
LEASES | |
Schedule of supplemental cash flow information and non-cash activity related to operating leases | The following table summarizes supplemental cash flow information and non-cash activity related to operating leases for the three months ended January 31, 2022 (in thousands): Three Months Ended January 31, 2022 Operating cash flow information: Cash paid for amounts included in the measurement of lease liabilities $ 1,219 Non-cash information: Right-of-use assets obtained in exchange for new operating lease liabilities $ 849 |
Schedule of maturities of undiscounted cash flows of lease commitments reconciled to the total lease liability | The following table summarizes the maturities of undiscounted cash flows of lease commitments reconciled to the total lease liability as of January 31, 2022 (in thousands): Remainder of 2022 $ 3,347 2023 3,122 2024 1,525 2025 841 2026 609 2026 and thereafter 1,089 Total 10,533 Less: Imputed interest (333) Present value of operating lease liabilities $ 10,200 |
GUARANTEES AND PRODUCT WARRAN_2
GUARANTEES AND PRODUCT WARRANTIES (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
GUARANTEES AND PRODUCT WARRANTIES | |
Schedule of reconciliation of the changes in warranty reserve | A reconciliation of the changes in our warranty reserve is as follows (in thousands): Three Months Ended January 31, 2022 2021 Balance, beginning of period $ 1,516 $ 1,200 Provision for warranties during the year 646 713 Charges to the reserve (680) (722) Impact of foreign currency translation (12) 55 Balance, end of period $ 1,470 $ 1,246 |
FINANCIAL INSTRUMENTS (Tables)
FINANCIAL INSTRUMENTS (Tables) | 3 Months Ended |
Jan. 31, 2022 | |
FINANCIAL INSTRUMENTS | |
Schedule of fair value hierarchy for financial assets and liabilities measured at fair value | In accordance with this guidance, the following table represents the fair value hierarchy for our financial assets and liabilities measured at fair value as of January 31, 2022 and October 31, 2021 (in thousands): Assets Liabilities January 31, 2022 October 31, 2021 January 31, 2022 October 31, 2021 Level 1 Deferred compensation $ 2,355 $ 2,481 $ — $ — Level 2 Derivatives $ 1,088 $ 905 $ 579 $ 467 |
DERIVATIVE INSTRUMENTS AND HE_3
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Fair value of derivative instruments (Details) - USD ($) $ in Thousands | Jan. 31, 2022 | Oct. 31, 2021 |
Derivatives, Fair Value [Line Items] | ||
Derivative assets | $ 1,088 | $ 905 |
Derivative liabilities | 579 | 467 |
Foreign Exchange Forward | Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | 917 | 646 |
Derivative liabilities | 440 | 403 |
Foreign Exchange Forward | Not Designated as Hedging Instrument | ||
Derivatives, Fair Value [Line Items] | ||
Derivative assets | 171 | 259 |
Derivative liabilities | $ 139 | $ 64 |
DERIVATIVE INSTRUMENTS AND HE_4
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Effect of derivative instruments (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) | $ 335 | $ (554) |
Amount of Gain (Loss) Reclassified from Other Comprehensive Income (Loss) | (149) | 379 |
Designated as Hedging Instrument | Foreign Exchange Forward | Intercompany sales/purchases | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) | 335 | (554) |
Amount of Gain (Loss) Reclassified from Other Comprehensive Income (Loss) | (149) | 379 |
Designated as Hedging Instrument | Foreign Exchange Forward | Net Investment Hedging | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain (Loss) Recognized in Other Comprehensive Income (Loss) | 69 | (110) |
Not Designated as Hedging Instrument | Foreign Exchange Forward | Other Income And Expense | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain (Loss) Recognized in Operations | $ 198 | $ (813) |
DERIVATIVE INSTRUMENTS AND HE_5
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Changes in components of accumulated other comprehensive loss (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
Derivative [Line Items] | ||
Beginning Balance | $ (1,741) | |
Other comprehensive income (loss) before reclassifications | (1,175) | |
Reclassifications | 149 | $ (379) |
Ending Balance | (2,767) | |
Foreign Currency Translation | ||
Derivative [Line Items] | ||
Beginning Balance | (1,668) | |
Other comprehensive income (loss) before reclassifications | (1,510) | |
Ending Balance | (3,178) | |
Cash Flow Hedging | ||
Derivative [Line Items] | ||
Beginning Balance | (73) | |
Other comprehensive income (loss) before reclassifications | 335 | |
Reclassifications | 149 | |
Ending Balance | $ 411 |
DERIVATIVE INSTRUMENTS AND HE_6
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Additional Information (Details) € in Millions | 3 Months Ended | |||
Jan. 31, 2022USD ($) | Jan. 31, 2021USD ($) | Nov. 30, 2021EUR (€) | Oct. 31, 2021USD ($) | |
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | $ 107,500,000 | $ 94,600,000 | ||
Gain (loss), net of tax, related to cash flow hedged | 335,000 | |||
Unrealized gain (loss), net of tax, to be reclassified in next 12 months | 313,000 | |||
Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Gains or (losses) from hedges deemed ineffective | 0 | $ 0 | ||
Not Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | 38,800,000 | |||
Forward Contracts | Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | € | € 3 | |||
Realized gain, net of tax, recorded as cumulative translation adjustments in Accumulated Other Comprehensive Loss | 900,000 | |||
Unrealized gain, net of tax, recorded as cumulative translation adjustments in Accumulated Other Comprehensive Loss | (68,000) | |||
Euros | Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | 23,600,000 | |||
Pounds Sterling | Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | 8,800,000 | |||
New Taiwan Dollars | Designated as Hedging Instrument | ||||
Derivative financial instruments: | ||||
Notional principal of foreign exchange contracts | $ 31,400,000 |
EQUITY INCENTIVE PLAN - Stock o
EQUITY INCENTIVE PLAN - Stock option activity (Details) - Employee Stock Option | 3 Months Ended |
Jan. 31, 2022$ / sharesshares | |
Stock Options | |
Outstanding at beginning of period | shares | 16,996 |
Options granted | shares | 0 |
Options exercised | shares | (5,437) |
Options cancelled | shares | 0 |
Outstanding at end of period | shares | 11,559 |
Weighted Average Exercise Price | |
Outstanding at beginning of period | $ / shares | $ 22.71 |
Options granted | $ / shares | 0 |
Options exercised | $ / shares | 21.45 |
Options cancelled | $ / shares | 0 |
Outstanding at end of period | $ / shares | $ 23.30 |
EQUITY INCENTIVE PLAN - Outstan
EQUITY INCENTIVE PLAN - Outstanding stock options vested (Details) | 3 Months Ended |
Jan. 31, 2022USD ($)$ / sharesshares | |
Options Already Vested and Currently Exercisable | |
Number of outstanding options | shares | 11,559 |
Weighted average remaining contractual life (years) | 10 months 9 days |
Weighted average exercise price per share | $ / shares | $ 23.30 |
Intrinsic value of outstanding options | $ | $ 103,000 |
EQUITY INCENTIVE PLAN - Reconci
EQUITY INCENTIVE PLAN - Reconciliation of restricted stock activity (Details) | 3 Months Ended |
Jan. 31, 2022$ / sharesshares | |
Number of Shares | |
Unvested at October 31, 2021 | shares | 262,556 |
Shares or units granted | shares | 98,700 |
Shares or units vested | shares | (24,053) |
Shares or units cancelled | shares | (61,500) |
Shares or units withheld | shares | (6,806) |
Unvested at January 31, 2022 | shares | 268,897 |
Weighted Average Grant Date Fair Value | |
Unvested at October 31, 2021 | $ / shares | $ 34.84 |
Shares or units granted | $ / shares | 31.71 |
Shares or units vested | $ / shares | 34.03 |
Shares or units cancelled | $ / shares | 38.41 |
Shares or units withheld | $ / shares | 34.03 |
Unvested at January 31, 2022 | $ / shares | $ 32.97 |
EQUITY INCENTIVE PLAN - Additio
EQUITY INCENTIVE PLAN - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions | Jan. 04, 2022 | Nov. 10, 2021 | Jan. 31, 2022 | Jan. 31, 2021 | Oct. 31, 2021 | Mar. 10, 2016 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Option expiration period | 10 years | |||||
Unrecognized Stock-based compensation expense | $ 5.9 | |||||
Restricted stock granted | 98,700 | |||||
Restricted stock vested | 24,053 | |||||
Grant date fair value of restricted stock | $ 32.97 | $ 34.84 | ||||
Performance period | 3 years | |||||
Stock-based compensation expense | $ 0.8 | $ 0.7 | ||||
2016 Equity Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Total number of shares of common stock that may be issued as awards under 2016 Plan | 856,048 | |||||
2008 Equity Plan | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Number of Shares Available for Grant under the 2008 Plan | 386,048 | |||||
PSU TSR | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Performance period | 3 years | |||||
PSU TSR | Minimum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Percentage of target number of shares to be earned | 50.00% | |||||
PSU ROIC | Maximum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Percentage of target number of shares to be earned | 200.00% | |||||
PSU ROIC | Minimum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Percentage of target number of shares to be earned | 50.00% | |||||
Time Based | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Restricted stock granted | 23,442 | 8,234 | ||||
Grant date fair value of restricted stock | $ 30.39 | $ 33.99 | ||||
Percentage of incentive compensation arrangement | 25.00% | |||||
Performance Based | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Percentage of incentive compensation arrangement | 75.00% | |||||
Performance period | 3 years | |||||
Performance Based | PSU TSR | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Restricted stock granted | 34,203 | |||||
Grant date fair value of restricted stock | $ 33.33 | |||||
Percentage of incentive compensation arrangement | 40.00% | |||||
Performance Based | PSU TSR | Maximum | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Percentage of target number of shares to be earned | 200.00% | |||||
Performance Based | PSU ROIC | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Restricted stock granted | 32,821 | |||||
Grant date fair value of restricted stock | $ 30.39 | |||||
Percentage of incentive compensation arrangement | 35.00% | |||||
Performance period | 3 years |
EARNINGS PER SHARE (Details)
EARNINGS PER SHARE (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
Basic | ||
Net income | $ 3,535 | $ 663 |
Undistributed earnings (loss) allocated to participating shares | (39) | (8) |
Net income (loss) applicable to common shareholders | $ 3,496 | $ 655 |
Weighted average shares outstanding | 6,616 | 6,575 |
Income (loss) per share | $ 0.53 | $ 0.10 |
Diluted | ||
Net income | $ 3,535 | $ 663 |
Undistributed earnings (loss) allocated to participating shares | (39) | (8) |
Net income (loss) applicable to common shareholders | $ 3,496 | $ 655 |
Weighted average shares outstanding prior to dilution effect | 6,616 | 6,575 |
Stock options and contingently issuable shares | 26 | 9 |
Weighted average shares outstanding | 6,642 | 6,584 |
Income (loss) per share | $ 0.53 | $ 0.10 |
ACCOUNTS RECEIVABLE (Details)
ACCOUNTS RECEIVABLE (Details) - USD ($) $ in Millions | Jan. 31, 2022 | Oct. 31, 2021 |
ACCOUNTS RECEIVABLE | ||
Allowance for Doubtful Accounts Receivable | $ 1.6 | $ 1.6 |
INVENTORIES (Details)
INVENTORIES (Details) - USD ($) $ in Thousands | Jan. 31, 2022 | Oct. 31, 2021 |
INVENTORIES | ||
Purchased parts and sub-assemblies | $ 44,011 | $ 37,527 |
Work-in-process | 17,483 | 17,559 |
Finished goods | 91,399 | 93,130 |
Inventories | $ 152,893 | $ 148,216 |
LEASES (Details)
LEASES (Details) - USD ($) $ in Millions | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
LEASES | ||
Operating lease expense | $ 1.3 | $ 1.3 |
Weighted-average remaining term | 3 years 8 months 12 days | |
Weighted-average discount rate | 1.70% | |
Minimum | ||
LEASES | ||
Lease term (in years) | 2 years | |
Maximum | ||
LEASES | ||
Lease term (in years) | 5 years |
LEASES - Supplemental cash flow
LEASES - Supplemental cash flow information (Details) $ in Thousands | 3 Months Ended |
Jan. 31, 2022USD ($) | |
LEASES | |
Cash paid for amounts included in the measurement of lease liabilities | $ 1,219 |
Right-of-use assets obtained in exchange for new operating lease liabilities | $ 849 |
LEASES - Maturities of undiscou
LEASES - Maturities of undiscounted cash flows of lease commitments (Details) $ in Thousands | Jan. 31, 2022USD ($) |
LEASES | |
Remainder of 2022 | $ 3,347 |
2023 | 3,122 |
2024 | 1,525 |
2025 | 841 |
2026 | 609 |
2026 and thereafter | 1,089 |
Total | 10,533 |
Less: Imputed interest | (333) |
Present value of operating lease liabilities | $ 10,200 |
SEGMENT INFORMATION (Narrative)
SEGMENT INFORMATION (Narrative) (Details) | 3 Months Ended |
Jan. 31, 2022segment | |
SEGMENT INFORMATION | |
Number of operating segments | 1 |
GUARANTEES AND PRODUCT WARRAN_3
GUARANTEES AND PRODUCT WARRANTIES - Reconciliation of the changes in warranty reserve (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Jan. 31, 2022 | Jan. 31, 2021 | |
GUARANTEES AND PRODUCT WARRANTIES | ||
Balance, beginning of period | $ 1,516 | $ 1,200 |
Provision for warranties during the period | 646 | 713 |
Charges to the reserve | (680) | (722) |
Impact of foreign currency translation | (12) | 55 |
Balance, end of period | $ 1,470 | $ 1,246 |
GUARANTEES AND PRODUCT WARRAN_4
GUARANTEES AND PRODUCT WARRANTIES - Additional Information (Details) $ in Millions | 3 Months Ended |
Jan. 31, 2022USD ($) | |
GUARANTEES AND PRODUCT WARRANTIES | |
Number Of Guarantees | 8 |
Guarantor Obligations, Maximum Exposure, Undiscounted | $ 0.8 |
Term of Product Warranty | 1 year |
DEBT AGREEMENTS (Details)
DEBT AGREEMENTS (Details) $ in Thousands, € in Millions, ¥ in Millions, $ in Millions | 3 Months Ended | |||||
Jan. 31, 2022USD ($) | Jan. 31, 2022TWD ($) | Jan. 31, 2022CNY (¥) | Jan. 31, 2022EUR (€) | Mar. 31, 2019TWD ($) | Mar. 31, 2019CNY (¥) | |
Line of Credit Facility [Line Items] | ||||||
Line of credit | $ 0 | |||||
Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | 40,000 | |||||
Line of credit, maximum borrowing capacity in alternative currencies | $ 20,000 | |||||
Variable interest rate | 0.00% | |||||
Line of Credit, covenant, minimum cash on hand before dividends are paid | $ 10,000 | |||||
Minimum working capital requirement | 125,000 | |||||
Minimum tangible net worth requirement | 176,500 | |||||
Line of Credit, covenant, maximum annual share repurchase | $ 10,000 | |||||
Line of credit, maturity date | Dec. 31, 2023 | |||||
Allowable investments in alternative investments | $ 10,000 | |||||
Borrowings available under credit facility | 52,200 | |||||
Hurco BV [Member] | Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | $ 20,000 | |||||
SOFR | Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Variable interest rate | 1.00% | |||||
Federal funds | Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Variable interest rate | 0.50% | |||||
Letter of Credit [Member] | Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | $ 10,000 | |||||
Stated interest rate | 1.00% | 1.00% | 1.00% | 1.00% | ||
Revolving Credit Facility [Member] | Line Of Credit Agreement 2018 [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | $ 40,000 | |||||
Revolving Credit Facility [Member] | Germany | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | € | € 1.5 | |||||
Taiwan credit facility [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | $ 150 | $ 150 | ||||
China credit facility [Member] | ||||||
Line of Credit Facility [Line Items] | ||||||
Line of credit, maximum borrowing capacity | ¥ | ¥ 32.5 | ¥ 32.5 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 3 Months Ended | ||
Jan. 31, 2022 | Jan. 31, 2021 | Oct. 31, 2021 | |
INCOME TAXES | |||
Income Tax Expense (Benefit) | $ 1,643,000 | $ 546,000 | |
Effective Income Tax Rate Reconciliation | 32.00% | 45.00% | |
Unrecognized Tax Benefits | $ 202,000 | $ 198,000 | |
Unrecognized tax benefits, interest accrued | $ 32,000 |
FINANCIAL INSTRUMENTS - Fair va
FINANCIAL INSTRUMENTS - Fair value hierarchy (Details) - Fair Value, Measurements, Recurring - USD ($) $ in Thousands | Jan. 31, 2022 | Oct. 31, 2021 |
Fair Value, Inputs, Level 1 | ||
Assets | ||
Deferred Compensation | $ 2,355 | $ 2,481 |
Liabilities | ||
Deferred Compensation | 0 | 0 |
Fair Value, Inputs, Level 2 | ||
Assets | ||
Derivatives | 1,088 | 905 |
Liabilities | ||
Derivatives | $ 579 | $ 467 |
FINANCIAL INSTRUMENTS - Additio
FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($) $ in Millions | Jan. 31, 2022 | Oct. 31, 2021 |
FINANCIAL INSTRUMENTS | ||
Notional amount of contracts | $ 107.5 | $ 94.6 |